Annual D&A
$15.00 K
+$1000.00+7.14%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual depreciation & amortization is $15.00 thousand, with the most recent change of +$1000.00 (+7.14%) on December 31, 2023.
- During the last 3 years, CANF annual D&A has risen by +$3000.00 (+25.00%).
- CANF annual D&A is now -80.92% below its all-time high of $78.60 thousand, reached on December 31, 2010.
Performance
CANF Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
June 30, 2024
Summary
- CANF quarterly depreciation & amortization is not available.
Performance
CANF Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
June 30, 2024
Summary
- CANF TTM depreciation & amortization is not available.
Performance
CANF TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
CANF Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.1% | - | - |
3 y3 years | +25.0% | - | - |
5 y5 years | +7.1% | - | - |
CANF Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +7.1% | ||||
5 y | 5-year | at high | +25.0% | ||||
alltime | all time | -80.9% | +25.0% |
Can-Fite BioPharma Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $15.00 K(+7.1%) | - | - |
Dec 2022 | $14.00 K(0.0%) | - | - |
Dec 2021 | $14.00 K(+16.7%) | - | - |
Dec 2020 | $12.00 K(-14.3%) | - | - |
Dec 2019 | $14.00 K(0.0%) | - | - |
Dec 2018 | $14.00 K(-26.3%) | - | - |
Dec 2017 | $19.00 K(+5.6%) | - | - |
Dec 2016 | $18.00 K(+9.8%) | - | - |
Dec 2015 | $16.40 K(+35.5%) | - | - |
Dec 2014 | $12.10 K(-27.5%) | - | - |
Dec 2013 | $16.70 K | $4300.00(-12.2%) | $16.60 K(-5.1%) |
Sep 2013 | - | $4900.00(+36.1%) | $17.50 K(-1.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2013 | - | $3600.00(-5.3%) | $17.80 K(+439.4%) |
Mar 2013 | - | $3800.00(-26.9%) | $3300.00(-85.6%) |
Dec 2012 | $23.00 K(-59.9%) | - | - |
Dec 2012 | - | $5200.00(0.0%) | $22.90 K(-21.8%) |
Sep 2012 | - | $5200.00(-147.7%) | $29.30 K(-14.1%) |
Jun 2012 | - | -$10.90 K(-146.6%) | $34.10 K(-44.6%) |
Mar 2012 | - | $23.40 K(+101.7%) | $61.50 K(+7.5%) |
Dec 2011 | $57.30 K(-27.1%) | - | - |
Dec 2011 | - | $11.60 K(+16.0%) | $57.20 K(+25.4%) |
Sep 2011 | - | $10.00 K(-39.4%) | $45.60 K(+28.1%) |
Jun 2011 | - | $16.50 K(-13.6%) | $35.60 K(+86.4%) |
Mar 2011 | - | $19.10 K | $19.10 K |
Dec 2010 | $78.60 K | - | - |
FAQ
- What is Can-Fite BioPharma annual depreciation & amortization?
- What is the all time high annual D&A for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual D&A year-on-year change?
- What is the all time high quarterly D&A for Can-Fite BioPharma?
- What is the all time high TTM D&A for Can-Fite BioPharma?
What is Can-Fite BioPharma annual depreciation & amortization?
The current annual D&A of CANF is $15.00 K
What is the all time high annual D&A for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual depreciation & amortization is $78.60 K
What is Can-Fite BioPharma annual D&A year-on-year change?
Over the past year, CANF annual depreciation & amortization has changed by +$1000.00 (+7.14%)
What is the all time high quarterly D&A for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly depreciation & amortization is $23.40 K
What is the all time high TTM D&A for Can-Fite BioPharma?
Can-Fite BioPharma all-time high TTM depreciation & amortization is $61.50 K